Find Your Daily Voice
Cliffside Park-Edgewater
Bogota Fairview Ridgefield
Serving Cliffside Park, Edgewater, Bogota, Fairview, and Ridgefield
Saturday, sep 7
62°
Follow
News
Schools
Business
Obituaries
Police & Fire
Weather
Lifestyle
Politics
Sports
Events
Traffic
Real Estate
Tags
Jobs
Shop
Support Us
Cliffside Park-Edgewater
Bogota Fairview Ridgefield
Follow
Find Your Daily Voice
News
Schools
Business
Obituaries
Police & Fire
Weather
Lifestyle
Politics
Sports
Events
Traffic
Real Estate
Tags
Jobs
Shop
Support Us
Home
About us
All sites
Advertise with us
Contact us
Terms of use
Privacy policy
Code of ethics
Site Map
© 2024 Cantata Media
62°
Saturday, sep 7
Tag:
Clinical Trial
News
$62K Raised For NJ Mom Battling 'Cancer With No Real Cure'
Danielle Rolon was in remission for two months before her cancer came back, but worse. Rolon, a Somerville mom, was diagnosed with breast cancer triple negative breast cancer when her third child was four months old, she said on a GoFundMe page she launched for herself and her family. She underwent five months of weekly chemotherapy, a double mastectomy and 25 rounds of radiation. Then, Rolon underwent a clinical trial and her cancer went into remission but it was short- lived. "I started to feel great and decided to get back to the gym," she writes. "After three days at the gy…
News
Every Cancer Patient In Remission After Miraculous Memorial Sloan Kettering Drug Trial
More than 15 rectal cancer patients who participated in a drug trial at Memorial Sloan Kettering Cancer Center are in remission. The first patient to try the drug was Washington DC's Sascha Roth, who got the good news on a Friday evening just four weeks before she was scheduled to undergo weeks of radiation therapy. More than a dozen others would soon receive the good news. The MSK clinical trial was investigating if immunotherapy alone could beat rectal cancer that had not spread to other tissues, in a subset of patients whose tumor contained a specific genetic mutation, the hospital sai…
News
Nj-b
ased Johnson & Johnson Pauses
Covid-
19 Vaccine Trial Due To Unexplained Participant Illness
New Jersey-based Johnson & Johnson has paused its COVID-19 vaccine study because of an unexplained illness among a participant. Researchers running the 60,000 patient trial received a notice saying the "pausing rule has been met," Stat News reports. The online patient-enrolling system was subsequently closed and a meeting for the patient safety monitoring board comprised of independent committee met Monday evening, the report says. J&J -- based in New Brunswick -- declined to tell Stat News anything more than a study participant suffered an unexplained illness. The company began e…